Characterization of Physiologically Relevant Ex Vivo Models
Time: 8:30 am
day: Conference Day 2
Details:
- Understanding pros and cons of working with patient-derived 3D tumour models
- Development of functional readouts pertinent to the selected models
- Assessment of ex vivo efficacy to immune modulators
